| (S)-nicotine | increases expression | ISO | RGD:1352767 | 6480464 | Nicotine results in increased expression of TXNDC9 mRNA | CTD | PMID:16949557 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TXNDC9 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:708355 | 6480464 | 2,4-dinitrotoluene affects the expression of TXNDC9 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:708355 | 6480464 | 2,6-dinitrotoluene affects the expression of TXNDC9 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:1352767 | 6480464 | beta-methylcholine affects the expression of TXNDC9 mRNA | CTD | PMID:21179406 |
| 8'-apo-beta,psi-caroten-8'-al | increases expression | ISO | RGD:1352767 | 6480464 | apocarotenal results in increased expression of TXNDC9 mRNA | CTD | PMID:17034753 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of TXNDC9 mRNA | CTD | PMID:19770486 |
| ammonium chloride | affects expression | ISO | RGD:708355 | 6480464 | Ammonium Chloride affects the expression of TXNDC9 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of TXNDC9 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TXNDC9 mRNA | CTD | PMID:19770486 |
| beta-carotene | increases expression | ISO | RGD:1352767 | 6480464 | beta Carotene results in increased expression of TXNDC9 mRNA | CTD | PMID:17034753 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TXNDC9 gene; more ... | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1352767 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNDC9 mRNA] | CTD | PMID:21858171 |
| cyclosporin A | increases expression | ISO | RGD:1352767 | 6480464 | Cyclosporine results in increased expression of TXNDC9 mRNA | CTD | PMID:20106945 |
| diarsenic trioxide | increases expression | ISO | RGD:1352767 | 6480464 | arsenic trioxide results in increased expression of TXNDC9 mRNA | CTD | PMID:20458559 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TXNDC9 gene; more ... | CTD | PMID:20938992 |
| furan | increases methylation | ISO | RGD:708355 | 6480464 | furan results in increased methylation of TXNDC9 gene | CTD | PMID:22079235 |
| hypochlorous acid | increases expression | EXP | | 6480464 | Hypochlorous Acid results in increased expression of TXNDC9 mRNA | CTD | PMID:19376150 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of TXNDC9; more ... | CTD | PMID:20938992 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of TXNDC9 mRNA | CTD | PMID:17562736 |
| piroxicam | multiple interactions | ISO | RGD:1352767 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNDC9 mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | ISO | RGD:1352767 | 6480464 | Piroxicam results in decreased expression of TXNDC9 mRNA | CTD | PMID:21858171 |
| thapsigargin | decreases expression | ISO | RGD:1352767 | 6480464 | Thapsigargin results in decreased expression of TXNDC9 protein | CTD | PMID:21692457 |